{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"cardiomyopathy-dilated-2e","columns":[{"gene":"","key":"population-919c7249251fea8fd6c6","label":"Cardiomyopathy, dilated, 2E","mondoId":"MONDO:0030366","onsetQualifier":null,"originColumnKey":"MONDO:0030366/OMIM:619492","originalViews":[{"key":"MONDO:0030366/OMIM:619492","label":"Cardiomyopathy, dilated, 2E","scopeLabel":"OMIM:619492","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1d57384d362167d50a1b3ec45daa7308791399c5240f685639b25df044a0d7a9","624d235e49aea6ab55e70c752c2db8c5817b4f780b9a74e2d145379f26e687ec","ab93cc79733aef117a3851bddf051e2f05ca60c6ce7a37a1c0d106c926e6c163"],"recordQualifiers":{},"scopeLabel":"OMIM:619492","sourceIds":["OMIM:619492"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-919c7249251fea8fd6c6"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001644","HP:0010316","HP:0006673"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"published":3}},"features":[{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":true},{"hpoId":"HP:0010316","label":"Ebstein anomaly of the tricuspid valve","primary":true},{"hpoId":"HP:0006673","label":"Reduced systolic function","primary":true}],"ledeHtml":"A dilated cardiomyopathy that is characterized by neonatal or early childhood onset of dilated cardiomyopathy, with rapid progression to cardiac failure and death unless patients undergo cardiac transplantation and that has material basis in homozygous or compound heterozygous mutation in the JPH2 gene on chromosome 20q13.","mondoId":"MONDO:0030366","node":{"canonicalSlug":"cardiomyopathy-dilated-2e","comparisons":[{"documentSha256":"e3774da0ae826255ce501d76d87f8720af0f22158c2d472e680129bc1a0f0b37","key":"legacy-cardiomyopathy-dilated-2e","kind":"legacy","label":"cardiomyopathy, dilated, 2E","memberIds":["MONDO:0030366"],"mondoId":"MONDO:0030366","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cardiomyopathy-dilated-2e.e3774da0ae826255ce501d76d87f8720af0f22158c2d472e680129bc1a0f0b37.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"cardiomyopathy, dilated, 2E","paragraphs":["A dilated cardiomyopathy that is characterized by neonatal or early childhood onset of dilated cardiomyopathy, with rapid progression to cardiac failure and death unless patients undergo cardiac transplantation and that has material basis in homozygous or compound heterozygous mutation in the JPH2 gene on chromosome 20q13."],"scope":"exact","source":"MONDO","upstream":"DOID:0081161","url":"https://monarchinitiative.org/MONDO:0030366"},"ownColumnKeys":["population-919c7249251fea8fd6c6"],"publication":"published","relationships":[{"kind":"parent","label":"familial isolated dilated cardiomyopathy","mondoId":"MONDO:0700335","slug":"familial-isolated-dilated-cardiomyopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/25554"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"1d57384d362167d50a1b3ec45daa7308791399c5240f685639b25df044a0d7a9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619492","disease_name":"Cardiomyopathy, dilated, 2E","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0006673","is_excluded":false,"label":"Reduced systolic function","onset_id":"HP:0003593","reference":"PMID:31227780","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"624d235e49aea6ab55e70c752c2db8c5817b4f780b9a74e2d145379f26e687ec","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619492","disease_name":"Cardiomyopathy, dilated, 2E","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0010316","is_excluded":false,"label":"Ebstein anomaly of the tricuspid valve","onset_id":"HP:0003577","reference":"PMID:31227780","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ab93cc79733aef117a3851bddf051e2f05ca60c6ce7a37a1c0d106c926e6c163","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619492","disease_name":"Cardiomyopathy, dilated, 2E","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":"HP:0003593","reference":"PMID:31227780","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030366\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0081161</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A dilated cardiomyopathy that is characterized by neonatal or early childhood onset of dilated cardiomyopathy, with rapid progression to cardiac failure and death unless patients undergo cardiac transplantation and that has material basis in homozygous or compound heterozygous mutation in the JPH2 gene on chromosome 20q13.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030366\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"cardiomyopathy-dilated-2e","sourceDocuments":[{"name":"MONDO: cardiomyopathy, dilated, 2E","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0030366"}],"sourceNote":"","synonyms":["cardiomyopathy, dilated, 2E","CMD2E"],"takeawayHtml":"","title":"cardiomyopathy, dilated, 2E"},"schemaVersion":1}
